Risk factors for hospitalized upper or lower gastrointestinal tract bleeding in treated hypertensives

被引:16
作者
Kaplan, RC
Heckbert, SR
Psaty, BM
机构
[1] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10461 USA
[2] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA
[3] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[4] Univ Washington, Dept Med, Seattle, WA 98195 USA
[5] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA
关键词
gastrointestinal hemorrhage; risk factors; epidemiology;
D O I
10.1006/pmed.2002.1008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. We examined risk factors for hospitalized gastrointestinal bleeding among health maintenance organization (HMO) members with hypertension. Methods. Case subjects (n = 199) were patients with hypertension hospitalized for confirmed gastrointestinal bleeding in 1992-1994. Control hypertensive subjects (n = 821) were selected from ongoing studies. Medical records and computerized pharmacy data were used to assess risk factors. Adjusted relative risks (RRs) were estimated using logistic regression models. Results. In multivariate-adjusted models, significant risk factors for upper gastrointestinal bleeding (n = 111 cases) were hepatic disease (RR = 2.85), elevated creatinine (IRR = 2.45), nonsteroidal anti-inflammatory drug use (RR = 2.28), smoking (RR = 1.93), cardiovascular disease (RR = 1.89), and physical inactivity (RR = 1.70). Risk factors for lower gastrointestinal bleeding (n = 43 cases) in multivariate-adjusted analyses were anticoagulant or thrombolytic therapy (RR = 3.80), elevated creatinine (RR = 2.31), and physical inactivity (RR = 2.10). Conclusions. This study confirmed several known risk factors for hospitalized gastrointestinal bleeding, including hepatic disease, renal dysfunction, and medication use, and also identified smoking and physical inactivity as independent risk factors. The magnitude of the relative risks associated with these behavioral factors suggests that lifestyle modification may substantially re. duce the risk of gastrointestinal bleeding. (C) 2002 American Health Foundation and Elsevier Science (USA).
引用
收藏
页码:455 / 462
页数:8
相关论文
共 21 条
[11]   Effects of cigarette smoking on gastric ulcer formation and healing: Possible mechanisms of action [J].
Ma, L ;
Chow, JYC ;
Cho, CH .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1998, 27 :S80-S86
[12]   Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study [J].
MacDonald, TM ;
Morant, SV ;
Robinson, GC ;
Shield, MJ ;
McGilchrist, MM ;
Murray, FE ;
McDevitt, DG .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7119) :1333-1337
[13]   Physical activity and cancer etiology: associations and mechanisms [J].
McTiernan, A ;
Ulrich, C ;
Slate, S ;
Potter, J .
CANCER CAUSES & CONTROL, 1998, 9 (05) :487-509
[14]   DISABILITY AND SEVERE GASTROINTESTINAL HEMORRHAGE - A PROSPECTIVE-STUDY OF COMMUNITY-DWELLING OLDER PERSONS [J].
PAHOR, M ;
GURALNIK, JM ;
SALIVE, ME ;
CHRISCHILLES, EA ;
MANTO, A ;
WALLACE, RB .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1994, 42 (08) :816-825
[15]   PHYSICAL-ACTIVITY AND RISK OF SEVERE GASTROINTESTINAL HEMORRHAGE IN OLDER PERSONS [J].
PAHOR, M ;
GURALNIK, JM ;
SALIVE, ME ;
CHRISCHILLES, EA ;
BROWN, SL ;
WALLACE, RB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (08) :595-599
[16]   THE RISK OF MYOCARDIAL-INFARCTION ASSOCIATED WITH ANTIHYPERTENSIVE DRUG THERAPIES [J].
PSATY, BM ;
HECKBERT, SR ;
KOEPSELL, TD ;
SISCOVICK, DS ;
RAGHUNATHAN, TE ;
WEISS, NS ;
ROSENDAAL, FR ;
LEMAITRE, RN ;
SMITH, NL ;
WAHL, PW ;
WAGNER, EH ;
FURBERG, CD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (08) :620-625
[17]  
Rothman KJ, 1986, MODERN EPIDEMIOLOGY
[18]   MULTIPLE IMPUTATION IN HEALTH-CARE DATABASES - AN OVERVIEW AND SOME APPLICATIONS [J].
RUBIN, DB ;
SCHENKER, N .
STATISTICS IN MEDICINE, 1991, 10 (04) :585-598
[19]  
Sorensen HT, 2000, AM J GASTROENTEROL, V95, P2218
[20]   Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs [J].
Weil, J ;
Langman, MJS ;
Wainwright, P ;
Lawson, DH ;
Rawlins, M ;
Logan, RFA ;
Brown, TP ;
Vessey, MP ;
Murphy, M ;
Colin-Jones, DG .
GUT, 2000, 46 (01) :27-31